Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours
Abstract NTRK gene fusions are rare somatic mutations found across cancer types with promising targeted therapies emerging. Healthcare systems face significant challenges in integrating these treatments, with uncertainty in prevalence and optimal testing methods to identify eligible patients. We per...
主要な著者: | Sophie O’Haire, Fanny Franchini, Yoon-Jung Kang, Julia Steinberg, Karen Canfell, Jayesh Desai, Stephen Fox, Maarten IJzerman |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Nature Portfolio
2023-03-01
|
シリーズ: | Scientific Reports |
オンライン・アクセス: | https://doi.org/10.1038/s41598-023-31055-3 |
類似資料
-
A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours
著者:: Yoon-Jung Kang, 等
出版事項: (2022-11-01) -
Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma
著者:: Simon Strohmeier, 等
出版事項: (2021-05-01) -
NTRK fusion in Japanese colorectal adenocarcinomas
著者:: Yuya Yamashiro, 等
出版事項: (2021-03-01) -
NTRK1 fusion in glioblastoma multiforme.
著者:: Jinkuk Kim, 等
出版事項: (2014-01-01) -
<i>NTRK</i> Fusions in 1113 Solid Tumors in a Single Institution
著者:: Heejin Bang, 等
出版事項: (2022-06-01)